Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Carcinoma, Invasive Ductal, Breast
Interventions: DRUG: Vinorelbine plus Capecitabine for 6 cycles, followed by Capecitabine|DRUG: Docetaxel plus Capecitabine for 6 cycles, followed by Capecitabine
Sponsor: Chinese Academy of Medical Sciences
Collaborators: Hoffmann-La Roche